Brittany Benko
Known title: Sr. VP, EHSCIK: 0001822144
Associated companies
Transaction History
| HUN | ▼ Sell | Tax Withholding | 630 | $8K | 2/13/2026 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 909 | $12K | 2/13/2026 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 1,281 | $17K | 2/13/2026 | View on chart |
| HUN | ▲ Buy | Grant | 26,375 | $0 | 2/12/2026 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 310 | $5K | 2/14/2025 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 603 | $10K | 2/14/2025 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 909 | $15K | 2/14/2025 | View on chart |
| HUN | ▲ Buy | Grant | 12,956 | $0 | 2/13/2025 | View on chart |
| HUN | ▲ Buy | Grant | 2,962 | $0 | 2/13/2025 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 879 | $15K | 2/13/2025 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 555 | $14K | 2/16/2024 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 749 | $18K | 2/16/2024 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 313 | $8K | 2/16/2024 | View on chart |
| HUN | ▲ Buy | Grant | 9,193 | $0 | 2/15/2024 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 2,488 | $60K | 2/15/2024 | View on chart |
| HUN | ▲ Buy | Grant | 9,220 | $0 | 2/15/2024 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 920 | $25K | 8/24/2023 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 912 | $28K | 2/17/2023 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 320 | $10K | 2/17/2023 | View on chart |
| HUN | ▲ Buy | Grant | 6,833 | $0 | 2/16/2023 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 920 | $27K | 8/24/2022 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 895 | $37K | 2/17/2022 | View on chart |
| HUN | ▲ Buy | Grant | 3,852 | $0 | 2/17/2022 | View on chart |
| HUN | ▼ Sell | Tax Withholding | 920 | $23K | 8/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Huntsman Faces New Coverage and Lowered Price Targets
Barclays initiated coverage on Huntsman with an Equal-Weight rating and a $10 price target. Meanwhile, Wells Fargo maintained its Equal-Weight stance but lowered its target to $9. These updates place the stock near the lower end of the $9 to $14 analyst range, reflecting cautious expectations for the company's performance.
Huntsman Faces New Coverage and Lowered Price Targets. Barclays initiated coverage on Huntsman with an Equal-Weight rating and a $10 price target. Meanwhile, Wells Fargo maintained its Equal-Weight stance but lowered its target to $9. These updates place the stock near the lower end of the $9 to $14 analyst range, reflecting cautious expectations for the company's performance.